Publication details
Malignant hyperthermia in Czechia and Slovakia
| Authors | |
|---|---|
| Year of publication | 2022 |
| Type | Article in Periodical |
| Magazine / Source | British Journal of Anaesthesia |
| MU Faculty or unit | |
| Citation | |
| Web | https://www.sciencedirect.com/science/article/abs/pii/S0007091222002422?via%3Dihub |
| Doi | http://dx.doi.org/10.1016/j.bja.2022.04.029 |
| Keywords | Malignant hyperthermia; Czechia; Slovakia |
| Attached files | |
| Description | Malignant hyperthermia (MH) is a rare, hereditary, life-threatening pharmacogenetic disorder triggered by some commonly used anaesthetics: all halogenated volatile anaesthetics and the depolarising neuromuscular blocking agent succinylcholine.1 Despite progress in common knowledge, diagnostics, and dantrolene availability, MH is still considered a severe anaesthetic complication. Genes pathogenically connected with MH include RYR1, CACNA1S, and STAC3.2 Prevalence of RYR1 variants associated with MH differs between countries and geographical areas.3 There is one MH diagnostic centre in the Slavic part of Europe located in Brno, Czechia that serves both Czech and Slovak patients. |
| Related projects: |
|